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Aim To test for differences in hemodynamic and analge-
sic properties in patients with breast cancer undergoing 
quadrantectomy with paravertebral block (PVB) induced 
with a solution of either one or two local anesthetics.
Method A prospective, single-center, randomized, dou-
ble-blinded, controlled trial was conducted from June 
2014 until September 2015. A total of 85 women with 
breast cancer were assigned to receive PVB with either 
0.5% levobupivacaine (n = 42) or 0.5% levobupivacaine 
with 2% lidocaine (n = 43). Hemodynamic variables of in-
terest included intraoperative stroke volume variation 
(SVV), mean arterial pressure, heart rate, cardiac output, 
episodes of hypotension, use of crystalloids, and use of in-
otropes. Analgesic variables of interest were time to block 
onset, duration of analgesia, and postoperative serial pain 
assessment using a visual analogue scale.
Results Although the use of 0.5% levobupivacaine with 
2% lidocaine solution for PVB decreased the mean time-
to-block onset (14 minutes; P < 0.001), it also caused sig-
nificantly higher SVV values over the 60 minutes of moni-
toring (mean difference: 4.33; P < 0.001). Furthermore, the 
patients who received 0.5% levobupivacaine with 2% li-
docaine experienced shorter mean duration of analgesia 
(105 minutes; P = 0.006) and more episodes of hypotension 
(17.5%; P = 0.048) and received more intraoperative crystal-
loids (mean volume: 550 mL; P < 0.001).
Conclusion The use of 0.5% levobupivacaine in compari-
son with 0.5% levobupivacaine with 2% lidocaine solu-
tion for PVB had a longer time-to-block onset, but it also 
reduced hemodynamic disturbances and prolonged the 
analgesic effect.
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Regional anesthesia is a technique whereby a local anesthet-
ic is injected near a nerve or the spinal cord in order to block 
or inhibit the reception of and response to pain and motor 
stimuli from a certain innervation area (1). Previous studies 
showed a high success of paravertebral block (PVB) for both 
anesthesia and postoperative analgesia in breast surgery 
(2-10). The technique of giving a local anesthetic for PVB dis-
tributed on several levels is better than a technique of giv-
ing it only at one level (11-13). Although significant hemo-
dynamic changes occur during the application of spinal and 
epidural anesthesia compared with PVB, there is a paucity 
of data about hemodynamic effects of different local anes-
thetics used for PVB (14,15). It has not yet been determined 
which type of local anesthetic solution has more favorable 
hemodynamic characteristics. Since the effects of local an-
esthetics on vasomotor tone are well known, we aimed to 
evaluate whether there were any relevant differences in he-
modynamic stability as the primary outcome and the dura-
tion of analgesia as the secondary outcome between two 
local anesthetic solutions, namely, 0.5% levobupivacaine 
and a combination of 0.5% levobupivacaine and 2% lido-
caine, in PVB for breast cancer surgery (14).
PATIENTS AND METHODS
This study was a single-center, randomized, controlled, 
double-blind trial conducted at Clinical Hospital Dubrava, 
Zagreb, Croatia, between June 2014 and September 2015.
Patients
The candidates for inclusion were consecutive women 
with breast cancer scheduled for surgical quadrantectomy 
with ipsilateral axillary lymph node dissection. The inclu-
sion criteria were age 18-80 years, body weight 50-95 kg, 
American Society of Anesthesiologists (ASA) physical sta-
tus I or II, and signed informed consent. The exclusion cri-
teria were coagulation disorders, infection in the areas of 
intended block application, neuropathy, failed PVB, uncon-
trolled psychiatric disorders, allergy to medications used in 
the trial, contraindications for the use of Vigileo / FloTrac 
system, and valvular diseases or abnormal heart rhythm.
Method
Study flow and double-blinding
The randomization schedule was computer-generated by 
a free online randomization service (16). Eligible patients 
were randomly allocated to receive either a thoracic PVB 
with levobupivacaine and lidocaine (LLG group, n = 43) or 
levobupivacaine alone (LG group, n = 42). The recruiting 
anesthesiologists and the anesthesia technicians who pre-
pared the local anesthetic solutions were blinded. The two 
solutions of local anesthetics were indistinguishable by ap-
pearance. The PVB was performed by a blinded anesthe-
siologist in the pre-operative holding area, while the pa-
tients received an infusion of 5-8 mL/kg of crystalloid 0.9% 
NaCl solution (Pliva, Zagreb, Croatia). After the confirma-
tion of a successful block according to the predefined cri-
teria, the patient was transferred into the operating room. 
All medical staff in the operating room, post-anesthesia 
care unit (PACU), and on the surgical ward were blinded to 
the allocated treatments. After the onset of PVB and gen-
eral anesthesia induction, the mean arterial pressure (MAP) 
and other hemodynamic parameters were measured us-
ing minimally invasive hemodynamic monitoring (Vigile-
oTM/FloTracTM system 4.0, Edwards Lifesciences, Irvine, CA, 
USA) for arterial pulse wave analysis. Fluid replacement 
was monitored continuously during the surgery, starting 
immediately after anesthesia induction. Surgical breast 
quadrantectomy with an ipsilateral axillary lymph node 
dissection was performed by the same two surgeons with 
more than 10 years of experience. The blinding was broken 
after the completion of data analysis.
Anesthesia procedure
All patients were premedicated with midazolam (Dormic-
um®, Roche) 0.06 mg/kg intramuscularly, 30 minutes be-
fore the operation. Electrocardiographic (ECG), non-invasive 
blood pressure (NIBP), and peripheral oxygen saturation 
(SpO2) monitoring was started in all patients immediately 
upon their arrival to the preoperative holding unit. After the 
skin infiltration with 0.5 mL of lidocaine 2% (Lidocaine®, Be-
lupo, Koprivnica, Croatia), an arterial cannula was placed in 
the radial artery. With the patient in the sitting position, the 
thoracic paravertebral spaces Th2, Th3, and Th4 were iden-
tified using an ultrasound machine (GE Healthcare Logiq 
Medical Ultrasound System, Wauwatosa, USA) with an ultra-
sonic linear probe of 8 Hz. We used a neurostimulator nee-
dle (Stimuplex HNS 12, B. Braun Melsungen AG, Germany) 
with a furnished intensity of 2.0 mA, duration of stimula-
tion of 0.1 ms, and a frequency of 1 Hz, together with the 
ultrasound, to identify the spinal nerves in the paravertebral 
space. With an in-plane technique, alongside the stimulated 
intercostal muscle contractions, we confirmed the position 
of the neurostimulator needle. At the onset of muscle con-
tractions with current strengths ranging from 0.4 to 0.6 mA, 
injections with the local anesthetic solution were applied 
on the ipsilateral side to levels Th2, Th3, and Th4 (7.0 mL 
per level), respectively (9,17). The solution of 0.5% 
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levobupivacaine (Chirocaine®, Abbott Laboratories, Dublin, 
Ireland) and 2% lidocaine (mixture of 7 mL of 2% lidocaine 
+14 mL of 0.5% levobupivacaine) was administered to the 
women in the LLG group, and 0.5% levobupivacaine alone 
was administered to the LG group. After that, the patients 
were positioned in the supine position and an experienced, 
blinded anesthesiologist tested the efficacy of the block us-
ing the pin prick test and warm-cold test every 5 minutes up 
to 30 minutes and the number of affected dermatomes. The 
onset time of the PVB was recorded as one of the primary 
analgesic outcome measures. The block was considered un-
successful if a patient did not have a positive response to the 
above tests between 15 and 30 minutes after administration 
of the two local anesthetic solutions and/or if the block was 
spread to less than four dermatomes. These patients were 
excluded from the trial and proceeded to general anesthe-
sia. After the successful performance of PVB, patients were 
moved to the operating room where their vital parameters 
(ECG, NIBP, and SpO2) were further monitored. General anes-
thesia induction was carried out with 1% propofol (10 mg/
mL, Fresenius) at a dose of 2 to 2.5 mg/kg intravenously and 
vecuronium bromide [Norcuron®, Schering – Plough,N.V. Or-
ganon, Netherlands] at a dose of 0.08 mg/kg intravenously, 
with a subsequent insertion of a laryngeal mask (I-Gel su-
praglottic airway) to maintain the airway. All patients were 
then ventilated by controlled mechanical ventilation with 
a volume of 8 mL/kg, frequency of 12 breaths per minute, 
with a mixture of oxygen and air at 40:60% ratio The main-
tenance of anesthesia and sedation was performed with a 
continuous infusion of 1% propofol to keep target values of 
a bispectral index (BIS) monitoring device A-2000 BIS moni-
tor (Aspect Medical Systems, Newton, MA, USA) in the 45-
55 range. Muscle relaxation was achieved with vecuronium 
bromide 0.1 mg/kg/h using a perfusion pump (B. Braun’s 
Perfusor®, Melsungen AG, Germany).
Hemodynamic monitoring
The stroke volume variation (SVV), MAP, heart rate (HR), and 
cardiac output (CO) were measured every 5 minutes dur-
ing the first 60 minutes from the onset of PVB, then every 
15 minutes during the next 60 minutes. If the operation 
lasted more than 2 hours, the measurements were carried 
out every 30 minutes. Fluid replacement with crystalloid 
solution was used to maintain a stable hemodynamic sta-
tus during the operation and was monitored in equally in 
all operated patients. In cases where the systolic blood 
pressure decreased below 100 mm Hg or by ≥30% from 
the baseline values, with bradycardia (HR<50 beats/min), 
we applied intravenously 5-10 mg of ephedrine hydro-
chloride (Ephedrine, Biotika, Prague, Czech Republic) 
and 0.5 mg of atropine sulfate (Atropine, Biotika) with a flu-
id bolus (5mL/kg/15 minutes). In cases where the systolic 
blood pressure increased by ≥30% from the baseline val-
ues due to inadequate analgesia, 1 µg/kg of fentanyl (Fen-
tanyl®, Janssen, Titusville, NJ, USA) was administered.
Postoperative care, pain assessment, and pain treatment
Postoperatively, the patients were taken to the PACU and 
their vital parameters (ECG, NIBP and SpO2) were record-
ed every 5 minutes. The hemodynamic monitoring system 
and the arterial cannula were removed. In case of any post-
operative nausea and vomiting or retching, the patients 
were given 0.1 mg/kg of thiethylperazine (Torecan®, Krka, 
Novo Mesto, Slovenia) intravenously. Once the patients ful-
filled the standard discharge criteria, they were transferred 
to the ward with the instruction of non-invasive monitor-
ing of vital parameters until complete block regression. 
Postoperative intensity of pain was evaluated using an 11-
point visual analogue scale (VAS; 0 = no pain; 10 = maximal 
pain). VAS scores were recorded by trained medical staff 
every 10 minutes while the patients were in the PACU. 
Once the patients were transferred to the ward, VAS scores 
were recorded every 3 hours for 24 hours after the opera-
tion. For moderate postoperative pain (VAS score from 3 to 
<6), the patients received 75 mg of diclofenac sodium (Vol-
taren, Pliva) intravenously in 100 mL of 0.9% NaCl over 15 
minutes. For severe postoperative pain (VAS score ≥6), the 
patients received a combination of 75 mg of diclofenac so-
dium intravenously and 100 mg of tramadol hydrochloride 
(Tramal®7, Herds) in 500 mL of 0.9% NaCl over 30 minutes. 
The total amount of administered postoperative analge-
sics was recorded at 12 and 24 hours postoperatively.
Outcome measures
The primary hemodynamic outcome was the SVV over the 
first 60 minutes after the induction of PVB, and the prima-
ry analgesic outcomes were time-to-block onset and du-
ration of analgesia. Secondary hemodynamic outcomes 
were HR, CO, MAP, episodes of hypotension, use of crys-
talloids, and the use of inotropes. The secondary analgesic 
outcome was a serial VAS pain assessment.
Statistical analysis
We assumed that a relative SVV difference between time 
over treatment in SVV of 60% would be practically and clini-
cally relevant and calculated the sample size and power of 
the study for repeated measures ANOVA under following 
conditions: power 95%, 13 repeated measurements, 2 treat-
ment groups, alpha 0.05, autocorrelation 0.5, and effect size 
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0.3 (assuming that the reference mean was 1, tested mean 
was 1.6, and SD within each group was 1). The estimated 
sample size was 80 subjects, or 40 subjects per group. GPow-
er for Windows, version 3.1.3, was used for data analysis.
Kolmogorov-Smirnov test was used to analyze the dis-
tribution of quantitative data. Socio-demographic indi-
cators and indicators of analgesia were analyzed using 
appropriate non-parametric tests, while the hemody-
namic values were analyzed using parametric tests. The 
comparisons between the quantitative values were as-
sessed using the Mann-Whitney U test. The differenc-
es in categorical values were analyzed with Fisher exact 
test. A two-way repeated measured analysis of variance 
(RM-ANOVA) was conducted to test the hypothesis that 
there were no changes in primary hemodynamic (SVV) 
and secondary hemodynamic parameters (MAP, HR and 
CO) over the first 60 minutes regarding time and treat-
ment over time interaction. Maulchy’s test of sphericity 
was performed to determine the appropriate correction 
of within-subject effects. Because there were no spheric-
ity assumed in any of RM-ANOVA tests, the Greenhouse-
Geisser correction was used to alter the degrees of free-
dom and produce an F-ratio where the type I error rate 
is reduced. Serial (repeated-measures) VAS scores were 
also analyzed by RM-ANOVA with VAS data previously ln 
(natural logarithm)-transformed. Overall and time-spe-
cific treatment differences were generated with adjust-
ment for multiplicity using Bonferroni correction (hemo-
dynamic outcomes significance was adjusted to 13 with 
the level of statistical significance <0.05/13 = 0.0038, and 
for VAS score to nine repeated pair-wise comparisons with 
the level of statistical significance <0.05/9 = 0.0055). In all 
other cases, P < 0.05 was considered significant. Statistical 
analyses were performed using the IBM SPSS Statistics for 
Windows, version 21.0 (IBM Corp., Armonk, NY, USA).
FIGurE 1. Flow diagram of breast cancer patients included in the trial.
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rESuLTS
A total of 85 patients were included in the trial. From them, 
5 patients (3 from the LLG group and 2 from the LG group) 
were excluded due to failed PVB (Figure 1). Statistical analy-
sis of patient characteristics, duration of surgery and  mo-
bilization after surgery, included  Mann Whitney U test and 
Fisher test and did not show significant differences be-
tween groups ( Table 1).
Primary and secondary hemodynamic outcomes
A two-way between-groups analysis of variance was con-
ducted to explore the impact of treatment over the time 
(Figures 2, 3, and 4; Table 2). The interaction effect between 
treatment groups and time was statistically significant only 
in SVV (F = 28.8; P < 0.001, Figure 2) indicating that there 
were significantly higher SVV values in LLG group during 
the 60 minutes of monitoring. The main significant differ-
ence between the groups occurred in the first 35 minutes 
(Figure 2). These data were also confirmed with the esti-
mated least-square (LS) means of difference showing a sig-
TABLE 1. Characteristics of breast cancer patients receiving paravertebral block, duration of surgery, and mobilization after surgery*
No. (%) of patients
Characteristics LG group (n = 40) LLG group (n = 40)
Age (years; median, 95% CI)  54.5 (50.0-60.0)  60.0 (55.0-67.0)
BMI (kg/m2; median, 95% CI)  24.6 (23.1-26.2)  26.2 (24.3-28.0)
Tumor localization: right breast  20 (50.0)  22 (55.0)
ASA PS 2  23 (57.5)  30 (75.0)
HA  13 (32.5)  17 (42.5)
Duration of surgery (minutes; median, 95% CI)  50.0 (50.0-60.0)  50.0 (50.0-60.0)
Mobilization after surgery (minutes; median, 95% CI (min) 240.0 (220.0-270.0) 205.0 (180.0-260.0)
*Abbreviations: LG – 0.5% levobupivacaine; LLG – 0.5% levobupivacaine + 2% lidocaine; CI –confidence interval; BMI – body mass index; ASA PS – 
American Society of Anesthesiologists; HA –arterial hypertension.
TABLE 2. Primary and secondary hemodynamic outcomes measured by minimally invasive hemodynamic monitoring (Vigileo/
FloTrac system) in breast cancer patients receiving paravertebral block: differences between treatment groups in estimated means 
over the time*
LS means (SE)
Hemodynamic outcomes LG group (n = 40) LLG group (n = 40) LS mean difference (95% CI)   P†
Primary
Overall SVV (%) over 60 minutes 11.13 (0.19) 15.47 (0.20) 4.33 (3.80-4.88) <0.001
Secondary
Overall MAP (mmHg) over time 90.42 (1.63) 90.01 (1.72) -0.41 (-5.18-4.37)  0.864
Overall HR (bpm) over time 66.17 (1.24) 66.75 (1.32) 0.58 (-3.05-4.21)  0.750
Overall CO (L/min) over 60 minutes  4.18 (0.10)  4.05 (0.11) -0.13 (-0.43-0.18)  0.414
*Abbreviations: LS – least square; SE – standard error; LG – 0.5% levobupivacaine; LLG – 0.5% levobupivacaine + 2% lidocaine; CI – confidence inter-
val; SVV – stroke volume variation; MAP – mean arterial pressure; Hr – heart rate; CO – cardiac output.
†rM-ANOVA.
FIGurE 2. The differences in the dynamics of stroke volume 
variation (SVV, %) between the test groups and the times 
of measurement according to the analysis of a variance for 
repeated measurements (0 denotes the initial hemodynamic 
values measured by Vigileo/FloTrac system after a successful 
block performance). Error bars represent mean values (95% 
confidence interval).
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nificantly higher value of SVV in the LLG group during the 
60 minutes of monitoring after the onset of PVB (P < 0.001) 
regarding time and treatment over time interaction (Table 
2). There were no significant differences in MAP, HR, and 
CO regarding treatment over time interaction. However, 
hemodynamic changes were significant over the moni-
tored time in all investigated parameters including SVV, 
MAP, HR, and CO in both treatment groups (Figures 2, 3, 
and 4.) Between the groups, there was a significant differ-
ence in the intraoperative fluid requirement of crystalloid 
infusion. The LLG group required more intraoperative flu-
id administration in comparison to the LG group (Table 3). 
Also, the incidence of hypotension was more common in 
the LLG group. There were no significant differences be-
tween groups in the use of ephedrine hydrochloride and 
atropine sulfate.
Intraoperative sedation and primary and secondary 
analgesic outcomes
There were no significant differences in the quantity of 
continuous infusion of propofol 1% between the groups 
(Table 3). The values of time from PVB administration to 
block onset and the duration of postoperative analgesia 
TABLE 3. Intraoperative sedation, primary analgesic and other secondary hemodynamic outcomes in the operated breast cancer 
patients receiving paravertebral block*
No. (%) of patients
Outcomes LG group (n = 40) LLG group (n = 40) P
Intraoperative sedation
Continuous doses of 1% propofol (µg/kg/min; median, 95% CI)  65.0 (60.0-70.0)   70.0 (70.0-80.0) 0.088†
Primary analgesic outcomes
Time-to-block onset (minutes; median, 95% CI)  37.0 (36.0-40.0)   23.0 (20.0-25.0) <0.001†
Duration of analgesia (minutes; median, 95% CI) 490.0 (460.0-520.0)  385.0 (350.0-460.0) 0.006†
Other secondary hemodynamic outcomes
Intraoperative crystalloids (mL; median, 95% CI) 600.0 (600.0-700.0) 1150.0 (1000.0-1300.0) <0.001†
Episodes of hypotension   2 (5.0)    9 (22.5) 0.048‡
Ephedrine hydrochloride, 5 mg iv.   2 (5.0)    7 (17.5) 0.154‡
Atropine sulfate, 0.5 mg iv.   0 (0)    3 (7.5) 0.241‡
*Abbreviations: LG – 0.5% levobupivacaine; LLG – 0.5% levobupivacaine + 2% lidocaine; CI – confidence interval.
†Mann-Whitney u test.
‡Fisher exact test.
FIGurE 3. The differences in the dynamics of (A) mean arterial pressure (MAP, mmHg) and (B) heart rate (Hr, bpm) between the test 
groups and the times (minutes) of measurement according to the analysis of a variance for repeated measures (0 indicates the initial 
values measured by hemodynamic Vigileo / FloTrac system after performing a successful block). Error bars represent mean (95% 
confidence interval).
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were both significantly lower in the LLG group than in the 
LG group. VAS scores at rest showed a significant increase 
3 hours after the surgery in the LLG group in comparison 
with those in the LG group, after which they became the 
same in both groups (Table 4). The significant changes in 
VAS score regarding time were confirmed by RM-ANO-
VA analysis (F = 31.0; P < 0.001), but there was no signifi-
cant difference in time over treatment interaction (F = 2.1; 
P = 0.069). Also, there were no differences in VAS scores be-
tween treatment groups in estimated means over the time 
(Table 4). Between the groups, there was a significant dif-
ference only in the amount of administered diclofenac so-
dium, as it was more frequently administered during the 
12 hours postoperatively in the LLG group than in the LG 
group (11/40 vs 4/40, respectively (P = 0.045). There was 
no need for additional administration of opioids in either 
group.
Perioperative complications and characteristics of PVB
There were no significant differences between the groups 
in the incidence of nausea, dizziness, and bradycardia (Ta-
ble 5).
Significantly lower values were noted in the LLG group re-
garding the time of onset of sensory block and regression 
of sensory block (Table 6). Accordingly, the times from PVB 
initiation to the first hemodynamic measurements were sig-
nificant lower in the LLG group than in the LG group. The 
TABLE 4. Visual analogue scale scores at rest before the operation, after the operation (at each time point), and throughout the 24-
hour measurement period in breast cancer patients receiving paravertebral block*
Median (95% CI) VAS score
VAS measurement timing LG group (n = 40) LLG group (n = 40) P
Before operation 1 (1.0-2.0) 1 (1.0-1.0) 0.270†
3 h postoperative 1 (1.0-2.0) 2 (2.0-4.0) 0.039†
6 h postoperative 2 (2.0-3.0) 2 (2.0-4.0) 0.286†
9 h postoperative 2 (2.0-4.0) 2 (2.0-4.0) 0.425†
12h postoperative 2 (2.0-4.0) 2 (2.0-4.0) 0.462†
15 h postoperative 2 (2.0-4.0) 2 (2.0-4.0) 0.544†
18 h postoperative. 2 (2.0-4.0) 2 (2.0-4.0) 0.580†
21 h postoperative 2 (2.0-4.0) 2 (2.0-4.0) 0.560†
24 h postoperative 2 (2.0-4.0) 2 (2.0-5.0) 0.574†
over 24 h (ln values; LS means, SE) 0.60 (0.03) 0.63 (0.03) 0.595‡
*Abbreviations: VAS – visual analogue scale; CI – confidence interval; LG – 0.5% levobupivacaine; LLG – 0.5% levobupivacaine +2% lidocaine; ln – 
natural logarithm; LS – least square, SE – Standard error.
†Mann-Whitney u test.
‡rM-ANOVA.
TABLE 5. Perioperative complications of paravertebral block in 
breast cancer patients*






(n = 40) P†
Nausea 1 (2.5) 2 (5.0) 0.999
Dizziness 4 (10.0) 4 (10.0) 1
Bradycardia 0 (0.0) 3 (7.5) 0.242
*Abbreviations: LG – 0.5% levobupivacaine; LLG – 0.5% levobupiva-
caine + 2% lidocaine.
†Fisher exact test.
FIGurE 4. The differences in the dynamics of cardiac output 
(CO, L/min) between the test groups and the times of mea-
surement according to the analysis of a variance for repeated 
measurements (0 denotes the initial hemodynamic values 
measured by Vigileo/FloTrac system after a successful block 
performance). Error bars represent mean (95% confidence 
interval).
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time between PVB application and surgical incision in the 
LLG group was significantly shorter than in the LG group.
DISCuSSION
The results of this trial showed that, for PVB, the administra-
tion of a single local anesthetic levobupivacaine in compari-
son with a solution of two different local anesthetics, 
levobupivacaine and lidocaine, had a more favorable hemo-
dynamic and analgesic profile. We decided to investigate 
these two types of local anesthetics because these are the 
most commonly used local anesthetics in our setting. The 
administration of one or two local anesthetics is equally ac-
ceptable for regional anesthesia, but mixing local anesthet-
ics may offer an advantage of having both fast onset from 
lidocaine and a long-lasting effect of levobupivacaine (9,13). 
Many authors advocate that anesthesia for breast surgery 
can be carried out either under PVB alone or in combination 
with general anesthesia (2,6-9). Accordingly, a recent meta-
analysis by Schnabel et al (9) showed that PVB, alone, or in 
combination with general anesthesia, results in better post-
operative analgesia with fewer adverse effects in compari-
son with other analgesic methods, such as postoperative 
rescue opioids or continuous infiltration via wound catheter 
infusion. Due to a high level of stress in breast cancer pa-
tients, we decided to combine PVB with general anesthesia 
in this trial (2). Although research has shown a high success 
of PVB in anesthesia and analgesia for breast surgery, it still 
remains unclear how the PVB affects hemodynamic vari-
ables with regard to the type and volume of administered 
local anesthetic solutions (2,4,5). Even though there are only 
few studies that mention the complications associated with 
ultrasound-guided PVB, the value of the ultrasound in the 
visualization of anatomical structures and in reducing com-
plications is undeniable (18). Using the “in-plane” ultrasound 
technique (visualization of the entire needle), we increased 
the degree of precision and managed to use smaller vol-
umes (7 mL per level) of local anesthetic solutions on multi-
ple levels, thereby attempting to avoid communication with 
the epidural space as much as possible (10-13). A neurostim-
ulator device enabled us to be even more precise, thereby 
decreasing the risk of possible nerve damage to the spinal 
nerves (6). Numerous studies showed an increased efficacy 
of PVB when applied on more levels, with fewer side effects 
(4-6,9,11-13). Lemay et al (12) reported that the administra-
tion of PVB on multiple levels did not lead to increased ab-
sorption of local anesthetics. Using the described methods, 
the failure rate of PVB was 5.9% in this study and between 
6.1% and 10.1% in other studies, which may have resulted 
from differences in technique (19,20). The continuous propo-
fol 1% infusion was adjusted according to BIS values in an 
attempt to alleviate the incidence of delirium and possible 
postoperative cognitive decline (21). Due to the variability of 
volatile anesthetics effect on BIS values, we decided to use 
intravenous anesthetics for the maintenance of anesthesia, 
because they have a more uniform effect on BIS values 
(22,23).We decided to conduct hemodynamic monitoring 
with the Vigileo/FloTrac system based on the previous stud-
ies on surgical patients (24-26). This device system also al-
lowed us to gain reliable data to define volume replacement 
and response to the same through changes in vessel tone 
measured by SVV (25,27). SVV represents a dynamic param-
eter showing the changing effect of intrathoracic pressure 
on venous return (24). It is also a good indicator and predic-
tor of intravascular volume (24,26,28). Accordingly, Slagt et al 
(25) have confirmed the pivotal role of SVV as a dynamic pa-
rameter in over 85% of studies. Also, SVV is affected by the 
changes of intrathoracic pressure induced by mechanical 
ventilation. In order to precisely monitor this parameter, the 
patient should be mechanically ventilated with a tidal vol-
ume of 8 ml/kg along with having a sinus rhythm on the 
ECG (29). The LLG group in our study had significantly higher 
SVV values from the beginning of measurement and in all 
subsequent measurements during the first hour. This may 
have occurred due to the shorter time required for the 
complete onset of the block, faster resorption, and stron-
ger vasodilating effects of the solution with two local an-
esthetics in the LLG group. Thus, in the LLG group, 
TABLE 6. Perioperative characteristics of paravertebral block in breast cancer patients*
Median (95% CI) time in minutes
Characteristics of PVB LG group (n = 40) LLG group (n = 40) P†
TSB onset   8.5 (8.0-10.0)   3.0 (3.0-4.0) <0.001
TSR end 490.0 (460.0-520.0) 385.0 (350.0-460.0)  0.007
Time from PVB administration to the first hemodynamic measurement  45.0 (45.0-48.0)  30.0 (30.0-35.0) <0.001
Time from PVB administration to incision  50.0 (50.0-55.0)  35.0 (35.0-40.0) <0.001
*Abbreviations: CI – confidence interval; LG – 0.5% levobupivacaine; LLG – 0.5% levobupivacaine + 2% lidocaine; TSB – time of sensory blockade; TSr 
– time of sensory regression; PVB – paravertebral block .
†Mann-Whitney u test.
CLINICAL SCIENCE278 Croat Med J. 2017;58:270-80
www.cmj.hr
measurements of the hemodynamic parameters (SVV, MAP, 
HR, CO) with the Vigileo/FloTrac system, commenced at a 
significantly earlier time compared to the LG group. During 
the first 60 minutes of SVV measurement, the hemodynamic 
values of SVV in the LG group were relatively stable and 
without significant differences within the group, which can 
be attributed to the longer time to a complete onset of 
block and slower resorption and vasodilation effect of the 
local anesthetic. After 60 minutes, there were no statistically 
significant differences in SVV between the groups due to 
the adequate volume replacement and correction of hemo-
dynamic derangements. We noted a significantly larger re-
quirement for intraoperative fluid volume replacement in 
the LLG group in comparison with the LG group. The reasons 
for this are the previously mentioned characteristics of PVB, 
which have resulted in higher values of SVV and lower val-
ues of MAP in the LLG group. With intraoperative crystalloid 
infusions for volume replacement, we attained a positive 
trend in the increase of MAP and a decrease in the variation 
of SVV between groups. Analogously, there was a decreased 
requirement for vasoactive agents in the LG group com-
pared with the LLG group. Therefore, we can conclude that 
SVV, as a dynamic parameter, has a significant role in clinical 
practice in the regulation and response to the administra-
tion of intravenous fluids and vasoactive agents. MAP and 
HR before and after the PVB onset were measured with non-
invasive methods, while in the operating room, they were 
measured with Vigileo/FloTrac system. The reason was that 
we wanted to be certain that the block was successful be-
fore using minimally invasive hemodynamic monitoring. To 
increase measurement precision, the measurement inter-
vals were set at 5 minutes during the first hour, while in oth-
er studies, measurements were set at 15-minute intervals 
during the first hour (3,30). Other trials also showed a signifi-
cant decrease in MAP values between 30 and 45 minutes 
from block administration (3,30). Garutti et al (30) explained 
the hypotension as due to the prompt resorption and vaso-
dilating effect of lidocaine and the unrecognized hypov-
olemic state of the patient. Our trial confirmed the results 
published by previous studies regarding the hemodynamic 
changes, namely the increase in SVV, decrease in MAP and 
CO, and minimal changes in HR (30,31). Casati et al (32) at-
tributed such changes to the effect of PVB on the peripheral 
and unilateral nerve blockade with resulting local vasodila-
tion and a minor sympathetic block. These effects primarily 
depend upon the used technique and type of local anes-
thetic. Previous studies, which investigated the effects of 
PVB on hemodynamics and used continuous hemody-
namic monitoring, were conducted in patients undergo-
ing lung surgery (30,33,34). During these operations, 
the PVB was not sufficient to provide complete intraopera-
tive analgesia and therefore, the authors needed to supple-
ment analgesia with significant quantities of opioids, there-
by directly affecting hemodynamic changes (30,33). Since 
we did not need to use opioids intraoperatively, the effects 
that the local anesthetic may have on hemodynamics were 
more pronounced. The prolonged analgesic effect in the LG 
group resulted in a significant reduction of postoperative 
non-steroidal anti-inflammatory drug (NSAID) administra-
tion during the first 12 hours postoperatively. Thus we have 
demonstrated that the administration of a solution with a 
single local anesthetic had a better analgesic effect. Investi-
gations comparing the combination of PVB and general an-
esthesia with general anesthesia alone in patients undergo-
ing breast surgery showed a significant reduction in opioid 
consumption, along with lower VAS pain scores during the 
first 24 hours postoperatively in the group where PVB was 
administered (35,36). PVB administration had enabled mobi-
lization in all patients in our study while maintaining the an-
algesic effects of the block. Considering that both groups 
reacted well to the postoperative administration of NSAIDs, 
there was no need for opioid administration. In this manner 
and according to previously published research, the inci-
dence of postoperative nausea and dizziness associated 
with opioid administration was reduced (2,7,8).
Our study has several limitations. The technique of choice 
in this trial requires a profound knowledge of human anat-
omy and ultrasound techniques. The application of con-
tinued postoperative analgesia via a perineural catheter 
would provide better analgesia and improve patient sat-
isfaction. Measurement of hemodynamic parameters with 
the FloTrac/Vigileo system was conducted after a confirma-
tion of a successful block and therefore, we were not able 
to measure SVV and CO before and during the block per-
formance. The usage of the FloTrac/Vigileo system in this 
setting requires a mechanically ventilated patient under 
general anesthesia (27). The assessment of SVV with the 
FloTrac/Vigileo system has not yet been investigated by di-
rect comparison with other techniques. Our patients were 
hypotensive at baseline because of pre-operative fasting, 
application of PVB, and anesthesia with propofol. Howev-
er, it seems likely that the present setting is close to most 
common clinical situations, with relative hypovolemia as 
one of the major causes of arterial hypotension.
The administration of a solution with a single local anes-
thetic, such as 0.5% levobupivacine, for PVB has a longer 
time-to-block onset in comparison with a solution of two 
local anesthetics, 0.5% levobupivacaine with 2% lidocaine, 
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along with a reduced impact on hemodynamic changes 
and a prolonged analgesic effect.
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